文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

原发性干燥综合征相关间质性肺病患者的特征及疾病进展的相关特征。

Characteristics of patients with primary Sjögren's syndrome associated interstitial lung disease and relevant features of disease progression.

机构信息

Division of Rheumatology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, 310005, China.

Division of Rheumatology, Ningbo No.6 Hospital, Ningbo, China.

出版信息

Clin Rheumatol. 2020 May;39(5):1561-1568. doi: 10.1007/s10067-019-04906-6. Epub 2020 Jan 5.


DOI:10.1007/s10067-019-04906-6
PMID:31902032
Abstract

OBJECTIVE: To investigate characteristics of patients with primary Sjögren's syndrome (pSS)-associated interstitial lung disease (ILD) and relevant features of ILD progression. METHOD: Patients with pSS were retrospectively reviewed, and pSS-ILD and pSS non-ILD were identified. Clinical data, laboratory parameters, pulmonary high-resolution CT (HRCT), and pulmonary function tests (PFTs) were collected. pSS-ILD patients were further categorized into subgroups according to HRCT patterns or PFTs. RESULTS: Eighty-five pSS-ILD patients and 85 pSS non-ILD patients were included. The average age at disease onset and median disease duration were significantly higher in pSS-ILD patients than those in pSS non-ILD patients (p < 0.001). Fever, xerostomia, xerophthalmia, and numbness were more frequent, and white blood cells, C reactive protein, and immunoglobulin G (IgG) levels were higher in pSS-ILD patients when compared to pSS non-ILD patients (p < 0.01). More male patients, older age at disease onset, and less frequent anti-Ro52 antibody were noted in patients with CT-usual interstitial pneumonia (UIP) pattern. In 49 patients with pSS-ILD, who repeated PFTs 6 months from the baseline, 79.6% were stable while 20.4% progressed, with ESR and CT-UIP pattern related with disease progression. CONCLUSIONS: Patients with pSS-ILD were characterized by more frequent fever, xerophthalmia, and elevated IgG levels, while male, older age at disease onset, and less frequent anti-Ro52 antibody were related with CT-UIP pattern. ESR and CT-UIP pattern were potential predictors for ILD progression.Key Points• pSS-ILD patients are characterized by more frequent fever, xerophthalmia and elevated IgG.• Anti-Ro52 antibody is less frequent in patients with CT-UIP pattern compared to non-UIP patterns.• ESR and CT-UIP pattern are associated with pSS-ILD progression.

摘要

目的:研究原发性干燥综合征(pSS)相关性间质性肺病(ILD)患者的特点及ILD 进展的相关特征。 方法:回顾性分析 pSS 患者,将其分为 pSS-ILD 组和 pSS 非-ILD 组。收集患者的临床资料、实验室指标、肺部高分辨率 CT(HRCT)及肺功能检查(PFT)结果。根据 HRCT 模式或 PFT 将 pSS-ILD 患者进一步分为亚组。 结果:共纳入 85 例 pSS-ILD 患者和 85 例 pSS 非-ILD 患者。pSS-ILD 组患者发病年龄和中位病程均显著高于 pSS 非-ILD 组(p<0.001)。与 pSS 非-ILD 组相比,pSS-ILD 组患者发热、口干、眼干、麻木更为常见,白细胞、C 反应蛋白和免疫球蛋白 G(IgG)水平更高(p<0.01)。CT-普通型间质性肺炎(UIP)模式患者中男性更多见、发病年龄更大、抗 Ro52 抗体更少。49 例 pSS-ILD 患者在基线时及 6 个月后重复进行 PFT,79.6%稳定,20.4%进展,ESR 和 CT-UIP 模式与疾病进展相关。 结论:pSS-ILD 患者发热、眼干、IgG 水平升高更为常见,而男性、发病年龄较大、抗 Ro52 抗体较少与 CT-UIP 模式相关。ESR 和 CT-UIP 模式是 ILD 进展的潜在预测因子。 关键点:

  • pSS-ILD 患者以发热、眼干和 IgG 升高为特征。
  • 与非 UIP 模式相比,CT-UIP 模式患者抗 Ro52 抗体较少。
  • ESR 和 CT-UIP 模式与 pSS-ILD 进展相关。

相似文献

[1]
Characteristics of patients with primary Sjögren's syndrome associated interstitial lung disease and relevant features of disease progression.

Clin Rheumatol. 2020-5

[2]
A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjögren's syndrome-related interstitial lung disease in a Chinese population.

Clin Rheumatol. 2018-9-22

[3]
Prognostic factors in interstitial lung disease associated with primary Sjögren's syndrome: a retrospective analysis of 33 pathologically-proven cases.

PLoS One. 2013-9-9

[4]
Clinical features and risk factors for primary Sjögren's syndrome combined with interstitial lung disease: a retrospective study.

Acta Biochim Pol. 2024

[5]
Angiopoietin-like protein 2 as a novel marker for patients with primary Sjogren's syndrome-related interstitial lung disease.

Clin Exp Med. 2020-8

[6]
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement.

Clin Rheumatol. 2017-6

[7]
Interstitial lung disease in primary Sjögren syndrome.

Chest. 2006-11

[8]
Risk factors for progression of interstitial lung disease in Sjögren's syndrome: a single-centered, retrospective study.

Clin Rheumatol. 2022-4

[9]
Respiratory infection risk in primary Sjögren's syndrome complicated with interstitial lung disease: a retrospective study.

Clin Rheumatol. 2024-2

[10]
Pulmonary manifestations of Sjögren's syndrome.

Respiration. 2009-4-22

引用本文的文献

[1]
Dynamics of serum tumor markers may indicate the progression of interstitial lung disease in Sjögren's syndrome patients: new roles for old friends.

Clin Exp Med. 2025-7-1

[2]
A Practical Multidisciplinary Approach to Identifying Interstitial Lung Disease in Systemic Autoimmune Rheumatic Diseases: A Clinician's Narrative Review.

Diagnostics (Basel). 2024-11-27

[3]
Long-term functional course of Sjögren's disease-associated interstitial lung disease.

ERJ Open Res. 2024-10-28

[4]
Meta-analysis of mortality-associated factors in primary Sjögren's syndrome patients with interstitial lung disease.

Clin Rheumatol. 2025-1

[5]
Screening, diagnosis, and monitoring of interstitial lung disease in autoimmune rheumatic diseases: A narrative review.

Rev Colomb Reumatol. 2024-4

[6]
Serum biomarker-based risk model construction for primary Sjögren's syndrome with interstitial lung disease.

Front Mol Biosci. 2024-8-21

[7]
Interstitial Lung Disease Phenotypes and Predictive Risk Factors in Primary Sjögren's Syndrome.

J Clin Med. 2024-8-22

[8]
Roles of TRIM21/Ro52 in connective tissue disease-associated interstitial lung diseases.

Front Immunol. 2024

[9]
Traditional Chinese medicine for sjögren's syndrome: a national survey of attitudes and perceptions among Chinese patients and rheumatologists.

BMC Complement Med Ther. 2024-7-30

[10]
Successful Immunosuppressive Therapy for Interstitial Lung Disease Associated with Sjögren's Syndrome with Double-positive Anti-SS-A and Anti-centromere Antibodies.

Intern Med. 2024-11-1

本文引用的文献

[1]
Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis.

Ann Rheum Dis. 2019-4-24

[2]
Interstitial lung disease in non-sicca onset primary Sjögren's syndrome: a large-scale case-control study.

Int J Rheum Dis. 2018-7

[3]
Risk factors for primary Sjögren syndrome-associated interstitial lung disease.

J Thorac Dis. 2018-4

[4]
Prevalence and spectrum of symptomatic pulmonary involvement in primary Sjögren's syndrome.

Clin Exp Rheumatol. 2018-5-29

[5]
Primary Sjögren's Syndrome.

N Engl J Med. 2018-3-8

[6]
Current Concepts in Pathogenesis, Diagnosis, and Management of Smoking-Related Interstitial Lung Diseases.

Chest. 2017-12-5

[7]
A review of the role and clinical utility of anti-Ro52/TRIM21 in systemic autoimmunity.

Rheumatol Int. 2017-8

[8]
Insight into pathogenesis of Sjögren's syndrome: Dissection on autoimmune infiltrates and epithelial cells.

Clin Immunol. 2017-9

[9]
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement.

Clin Rheumatol. 2017-6

[10]
Interstitial lung disease in primary Sjögren's syndrome.

Autoimmun Rev. 2016-9-25

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索